PMEL and melanoma: Eleven days post-dose, T cells from the tumor were responsive to multiple tumor associated antigens as demonstrated by IFNγ and granzyme B release after ex vivo stimulation with OVA or melanoma associated peptides (p53, TRP-2, gp100 and MAGE-A5) (Fig. 5g).